Danofloxacin mesylate sterile antimicrobial injectable solution for the treatment of bovine respiratory disease (BRD) associated with Mannheimia (Pasteurella) haemolytica and Pasteurella multocida. Each mL contains 180 mg of danofloxacin as the mesylate salt. Administer SQ in cattle only. Not for use in cattle intended for dairy production or in calves to be processed for veal. Meat withdrawal: 4 days.
Temperature Sensitive (Vaccines and Other Refrigerated Items) along with Rx products are non-returnable. exemptions apply.